Svetlana Nikic: Companies Don’t Even Know Where Their Access Barriers Actually Are
Svetlana Nikic, Founder at Precision Oncology Consulting, shared on LinkedIn:
“Entering the European market with a novel oncology diagnostic?
The biggest challenge I see: companies don’t even know where their access barriers actually are.
Every country has its own HTA bodies, processes, and funding timelines.
Some companies jump straight into evidence generation, only to realize they missed critical regional requirements.
Others underestimate hospital-level decision-making in decentralized systems.
Solution: That is why I now offer a 20-min Access Strategy Diagnostic Call: an opportunity for us to meet, get to know your product and present you our solutions which ultimately will enable you faster access across European Healthcare system. Message me directly or book your slot following.”
More posts featuring Svetlana Nikic.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023